KR900004759A - 플루오로-치환 에피포도필로톡신 배당체 - Google Patents

플루오로-치환 에피포도필로톡신 배당체 Download PDF

Info

Publication number
KR900004759A
KR900004759A KR1019890012830A KR890012830A KR900004759A KR 900004759 A KR900004759 A KR 900004759A KR 1019890012830 A KR1019890012830 A KR 1019890012830A KR 890012830 A KR890012830 A KR 890012830A KR 900004759 A KR900004759 A KR 900004759A
Authority
KR
South Korea
Prior art keywords
compound
formula
substituted
alkyl
thienyl
Prior art date
Application number
KR1019890012830A
Other languages
English (en)
Other versions
KR920000646B1 (ko
Inventor
오누마 다께시
야마사끼 데쓰로
가메이 히데오
나이또 다까유끼
Original Assignee
아이삭 자아코브스키
브리스톨-마이어즈 컴페니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아이삭 자아코브스키, 브리스톨-마이어즈 컴페니 filed Critical 아이삭 자아코브스키
Publication of KR900004759A publication Critical patent/KR900004759A/ko
Application granted granted Critical
Publication of KR920000646B1 publication Critical patent/KR920000646B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

내용없음

Description

플루오르-치환 에피포도필로톡신 배당체
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (7)

  1. 다음의 일반식을 갖는 화합물
    상기 일반식중, R2는 H이고 R1은 (C1-10)알킬; (C2-10)알케닐; (C5-6)시클로알킬; 2-퓨릴; 2-티에닐; (C6-10)아릴; (C7-14)아르알킬; 및 (C8-14)아르알케닐 중에서 선택되며, 여기서 각 방향족 고리는 할로, (C1-8)알킬, (C1-8)알콕시, 히드록시, 니트로 및 아미노 중에서 선택된 하나이상의 기로 치환되거나 치환되지 않을 수 있으며; 또는 R1및 R2는 각각 (C1-8)알킬이거나; 또는 R1및 R2는 이들이 결합되어 있는 탄소원자와 함께 (C5-6) 시클로알킬기를 형성하고; R3또는 R4중 하나는 OH이고 다른 하나는 F이며; R5는 H 또는 페놀보호기이고; 는 α- 또는 β-글리코시드 결합을 나타낸다.
  2. 제1항에 있어서, R2 및 R5가 각각 H이고, R1은 메틸, 2-티에닐 및 페닐 중에서 선택되는 것이 특징인 화합물.
  3. 다음의 구조식을 갖는 화합물
  4. 다음의 구조식을 갖는 화합물
  5. 다음의 구조식을 갖는 화합물
  6. 제1항의 화합물의 항종양 유효량과 약리적으로 허용되는 담체로 이루어짐을 특징으로 하는 항종양제 조성물.
  7. 종양 보유 포유류 숙주에 제1항의 화합물의 항종양 유효량을 투여함을 특징으로 하는 악성 종양의 치료방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890012830A 1988-09-06 1989-09-05 플루오로-치환 에피포도필로톡신 배당체 KR920000646B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/240,971 US4912204A (en) 1988-09-06 1988-09-06 Fluoro-substituted epipodophyllotoxin glucosides
US240,971 1988-09-06
US240971 1988-09-06

Publications (2)

Publication Number Publication Date
KR900004759A true KR900004759A (ko) 1990-04-13
KR920000646B1 KR920000646B1 (ko) 1992-01-20

Family

ID=22908678

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890012830A KR920000646B1 (ko) 1988-09-06 1989-09-05 플루오로-치환 에피포도필로톡신 배당체

Country Status (14)

Country Link
US (1) US4912204A (ko)
EP (1) EP0358197A3 (ko)
JP (1) JPH02115194A (ko)
KR (1) KR920000646B1 (ko)
AU (1) AU606536B2 (ko)
CA (1) CA1323628C (ko)
DK (1) DK169240B1 (ko)
FI (1) FI894124A (ko)
HU (1) HU205132B (ko)
IL (1) IL91521A (ko)
NO (1) NO170687C (ko)
NZ (1) NZ230496A (ko)
YU (1) YU161989A (ko)
ZA (1) ZA896778B (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5061791A (en) * 1988-12-21 1991-10-29 Warner-Lambert Company 4-bromo-4'-demethylepipodophyllotoxin derivatives
US4965348A (en) * 1989-05-19 1990-10-23 Bristol-Myers Company Dimeric epipodophyllotoxin glucoside derivatives
US5036055A (en) * 1989-06-07 1991-07-30 Bristol-Myers Company Acylated derivatives of etoposide
US5034380A (en) * 1989-11-20 1991-07-23 Bristol-Myers Squibb Company Alkoxymethylidene epipodophyllotoxin glucosides
US5081234A (en) * 1990-04-30 1992-01-14 Bristol-Myers Squibb Co. 4'-demethylepipodophyllotoxin glycosides
US6207673B1 (en) 1997-03-12 2001-03-27 The University Of North Carolina At Chapel Hill Covalent conjugates of topoisomerase I and topoisomerase II inhibitors
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
EP1881000A1 (en) * 2006-07-17 2008-01-23 Institut National De La Sante Et De La Recherche Medicale (Inserm) Conjugates of 2-fluoro-2-deoxy-glucose and their uses as anti cancer agents
CN102115483B (zh) * 2009-12-30 2014-12-17 苏州天人合生物技术有限公司 卤代双去氧糖衍生物及其制备方法与应用
CN103739635B (zh) * 2014-01-22 2016-05-25 江苏省原子医学研究所 一种三氟甘露糖中间体的纯化方法
CN115141208B (zh) * 2022-08-05 2024-03-08 贵州大学 一种含各类酯基结构的鬼臼毒素类化合物及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1171314A (fr) * 1955-05-13 1959-01-23 Sandoz Ag Produits de condensation de glucosides avec des composés carbonyliques et leur préparation
NL6613143A (ko) * 1965-09-21 1967-03-22
EP0111058B1 (en) * 1982-11-26 1987-11-04 Nippon Kayaku Kabushiki Kaisha Process for producing 4'-demethyl-epipodophyllotoxin-beta-d-ethylidene-glucoside and acyl-derivative thereof
JPS6032799A (ja) * 1983-07-29 1985-02-19 Microbial Chem Res Found 新規４′−デメチル−４−エピポドフィロトキシン誘導体
JPS60246393A (ja) * 1984-05-22 1985-12-06 Nippon Kayaku Co Ltd エトポシドの新規製造法
JPS61227590A (ja) * 1985-04-02 1986-10-09 Microbial Chem Res Found 新規４′−デメチル−４−エピポドフイロトキシン誘導体
IL77334A (en) * 1985-12-16 1991-04-15 Univ Bar Ilan Synthesis of 9-epipodophyllotoxin glucoside derivatives and some novel intermediates therefor
CN1042362A (zh) * 1988-10-31 1990-05-23 布里斯托尔-米尔斯公司 表鬼臼脂素糖苷的磷酸和磺酸酯的制备方法

Also Published As

Publication number Publication date
AU4115089A (en) 1990-04-26
NZ230496A (en) 1991-11-26
NO893548D0 (no) 1989-09-05
NO893548L (no) 1990-03-07
JPH0567640B2 (ko) 1993-09-27
AU606536B2 (en) 1991-02-07
YU161989A (en) 1991-02-28
FI894124A (fi) 1990-03-07
CA1323628C (en) 1993-10-26
DK439589A (da) 1990-03-07
EP0358197A2 (en) 1990-03-14
DK169240B1 (da) 1994-09-19
EP0358197A3 (en) 1991-04-03
IL91521A (en) 1994-01-25
NO170687B (no) 1992-08-10
HU205132B (en) 1992-03-30
DK439589D0 (da) 1989-09-05
US4912204A (en) 1990-03-27
JPH02115194A (ja) 1990-04-27
KR920000646B1 (ko) 1992-01-20
HUT51284A (en) 1990-04-28
IL91521A0 (en) 1990-04-29
NO170687C (no) 1992-11-18
ZA896778B (en) 1990-06-27
FI894124A0 (fi) 1989-09-01

Similar Documents

Publication Publication Date Title
RU2225404C2 (ru) ПРОИЗВОДНЫЕ ПИПЕРАЗИНА, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ОБЛАДАЮЩАЯ ИНГИБИРУЮЩЕЙ АКТИВНОСТЬЮ В ОТНОШЕНИИ ФАКТОРА Хa
KR900004759A (ko) 플루오로-치환 에피포도필로톡신 배당체
KR890005200A (ko) 에폭시 수지에 대한 경화제인 시아노구아니딘
KR950002755A (ko) 워트마닌 및 그의 유사체에 의한 포스파티딜이노시톨 3-키나제의 억제
KR970701708A (ko) 9-데옥소탁산 화합물(9-Deoxotaxane compounds)
KR910000778A (ko) 에토포시드의 아실화 유도체
KR930702318A (ko) 이속사졸 화합물, 그의 약제학적으로 허용되는 염 및 그의 의학적 용도
KR890005336A (ko) 합성섬유처리용 내열성 유제 조성물
KR870007190A (ko) 유기백금착물, 이를 사용한 종양 치료방법 및 이를 함유하는 조성물
KR890009962A (ko) 매뉴마이신 유도체, 이의 제조방법 및 용도
KR910009266A (ko) 수의학 약제로서 유용한 피리돈-카르복실산 유도체
KR890011602A (ko) 안과용 조성물과 그 제조방법
KR880001764A (ko) 열가소성 폴리에스테르 수지조성물
KR910004557A (ko) 2,4,6-치환 페놀 유도체
KR860003201A (ko) 톨루엔디아민 조성물
KR880013965A (ko) 에피포도필로톡신 배당체의 질소함유 유도체
ES413926A1 (es) Un procedimiento para curar una resina curable al acido.
KR890003793A (ko) 3'-데메톡시에피포도필로톡신 배당체의 유도체
KR900006359A (ko) 에피포도필로톡신 글루코시드의 인산 및 술폰산당
KR910000866A (ko) 폴리아릴렌 술피드 수지조성물
KR880000499A (ko) 열가소성 폴리에스테르 수지조성물
EP0959088A3 (en) An epoxy-resin composition and use thereof
KR910009720A (ko) 알콕시메틸리덴 에피포도필로톡신 배당체
KR900700097A (ko) 항종양제 백금-아민-설폭시드
JPS5614566A (en) Resin composition for process release paper

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee